Antimicrobial peptides
US8691945B2 · kind B2 · utility
0Cited by
17References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 27, 2007 |
| Grant date | Apr 8, 2014 |
| Priority date | — |
| Expiry date | Jul 1, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided at least one isolated antimicrobial peptide, wherein the peptide is a linear analog of hBD3 or a fragment thereof. In particular, there is provided a linear analog of hBD3 wherein the peptide has a reduced cytotoxicity to at least one cell compared to the wild type hBD3.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.